Abstracts Archive - Page 271 of 1683 - ATC Abstracts

2021 American Transplant Congress
Impact of Insulin Therapy in Pancreas Transplantation Donors on Graft Outcomes: An Analysis of the Optn/unos Database
E. Montagud-Marrahi¹, F. Ausania², Y. Fundora², A. Amor³, E. Esmatjes³, J. Ferrer², I. Revuelta¹, D. Cucchiari¹, J. Rovira⁴, M. Musquera⁵, C. Fondevila², F. Diekmann¹, P. Ventura-Aguiar¹
¹Nephrology and Kidney Transplantation Department, Hospital Clinic de Barcelona, Barcelona, Spain, ²Hepatobiliopancreatic and Liver Transplant Department, Hospital Clinic de Barcelona, Barcelona, Spain, ³Endocrinology Department, Hospital Clinic de Barcelona, Barcelona, Spain, ⁴Laboratori Experimental de Nefrologia I Trasplantament (LENIT), CRB CELLEX, Fundació Clínic, IDIBAPS, Hospital Clinic de Barcelona, Barcelona, Spain, ⁵Urology Department, Hospital Clinic de Barcelona, Barcelona, Spain
*Purpose: Hyperglycemia requiring insulin treatment is frequent in critically ill patients and potential pancreas donors. Information on the impact of donor insulin use on pancreas…
2021 American Transplant Congress
SARS-CoV-2 Infection in Solid Organ Transplant Recipients: A Retrospective Cohort Study
A. Adeel
Infectious Diseases, University of Massachusetts, Worcester, MA
*Purpose: Initial studies of COVID-19 in solid organ transplant (SOT) recipients demonstrated high mortality rates, but more recent comparative data shows contradictory results.*Methods: We evaluated…
2021 American Transplant Congress
Patient Perspective of the Implementation of Virtual Medicine in a Post-kidney Transplant Clinic
S. Mann¹, M. Kadatz¹, J. Lan¹, O. Johnston¹, C. Luo²
¹Medicine, Division of Nephrology, University of British Columbia, Vancouver, BC, Canada, ²Pharmaceutical Sciences, Vancouver General Hospital, Vancouver, BC, Canada
*Purpose: COVID-19 dramatically altered the model of health care delivery for transplant recipients, necessitating the routine use of virtual medicine. This resulted in consequences for…
2021 American Transplant Congress
Cancer-Specific Mortality in Solid Organ Transplant Recipients with a Prior Cancer Diagnosis
E. Engels¹, G. Haber¹, A. Hart², C. Lynch³, J. Li⁴, K. Pawlish⁴, B. Qiao⁵, K. Yu¹, R. Pfeiffer¹
¹Natl Cancer Inst, Bethesda, MD, ²Univ of Minnesota, Minneapolis, MN, ³Univ of Iowa, Iowa City, IA, ⁴New Jersey Dept of Health, Trenton, NJ, ⁵New York State Dept of Health, Albany, NY
*Purpose: A history of cancer is increasingly common among solid organ transplant candidates, and transplant-associated immunosuppression may increase recurrence risk. We assessed whether transplantation was…
2021 American Transplant Congress
Human Leukocyte Antigen Mismatches Between Donor-Recipient or Donor-Donor are Not Associated with Adverse Pancreas Outcomes in Pancreas After Kidney Transplant Recipients
S. Parajuli, D. Kaufman, B. Welch, H. Sollinger, D. Mandelbrot, J. Odorico
University of Wisconsin, MADISON, WI
*Purpose: A greater degree of HLA mismatch has been previously associated with inferior graft survival in kidney and pancreas transplantation. Pancreas after kidney (PAK) recipients…
2021 American Transplant Congress
Hospital-Level Metrics and Interventions to Increase Deceased Organ Donation: A Systematic Review
M. Castillo-Angeles¹, G. Li², P. Bain³, A. Salim¹, J. T. Adler¹
¹Surgery, Brigham and Women's Hospital, Boston, MA, ²Brandeis University, Waltham, MA, ³Harvard Medical School, Boston, MA
*Purpose: The shortage of transplantable organs available for the ever-growing transplant waiting list is well-described. Efforts to ameliorate this have predominantly focused on improving processes…
2021 American Transplant Congress
Pd-1 Inhibitor Treatment in Solid Organ Transplant Patients with Metastatic Cancer
C. Chung¹, H. Ko¹, H. Kim¹, K. Choi¹, A. Han¹, S. Min¹, H. Kang², J. Ha¹
¹Department of Surgery, Seoul National University College of Medicine, Seoul, Korea, Republic of, ²Department of Pediatrics, Seoul National University College of Medicine, Seoul, Korea, Republic of
*Purpose: Solid organ transplant patients due to chronic immunosuppression have an increased risk of de novo cancer. Immune checkpoint inhibitors have been recently developed to…
2021 American Transplant Congress
Intravenous Immunoglobulin Protects Liver Allograft from Ischemia Reperfusion Injury in Human Liver Transplantation
S. Yokota, J. C. Alonso-Escalante, R. P. Tindall, K. R. Tabar, L. Machado, T. Uemura, N. L. Thai
Department of Surgery, Allegheny General Hospital, Pittsburgh, PA
*Purpose: Ischemia/reperfusion (I/R) injury following prolonged cold storage has a significant impact on early and late human liver transplantation (LTx) outcomes. Prevention of I/R injury…
2021 American Transplant Congress
Nurse and Nurse Practitioner-lead Monoclonal Antibody Initiative for Solid Organ Transplant (sot) Recipients with Covid-19
W. Cochran¹, R. Avery², D. Brennan², N. Lawrence², A. Brown², S. Sullivan², B. Adams², M. McCarthy², S. Ellis², F. Naqvi², E. Kraus², N. Alachkar², S. Alasfar², F. Al Ammary², J. Horn², L. Hartman², L. Fessler², S. Purekal², Z. Siddiqui², D. Carter², J. Ficke², M. Kantsiper², L. Boyer², I. Gupta², A. Gurakar², D. Ostrander², J. Langlee², S. Shoham², K. Marr², P. Shah²
¹Johns Hopkins Comprehensive Transplant Center, Baltimore, MD, ²Johns Hopkins, Baltimore, MD
*Purpose: Monoclonal antibody (mAB) infusion (bamlanivimab or casirivimab/imdevimab) for symptomatic, non-hypoxemic, high-risk outpatients with COVID-19 infection, is an available early intervention for COVID-19+ SOT recipients.…
2021 American Transplant Congress
Survey of Transplantation Providers to Assess for Implicit Bias at a Single Center
C. Ramirez-Sanchez¹, A. Cardenas², S. Aslam¹, F. Ferguson², M. Vazquez², T. Magee², K. Mekeel²
¹Infectious Diseases, University of California San Diego, La Jolla, CA, ²University of California San Diego, La Jolla, CA
*Purpose: At our institution’s Center for Transplantation, the Implicit Bias Working Group (IBWG), was formed with the aim to comprehend how implicit biases impact the…